Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7482)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2016 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cox IJ, Aliev AE, Crossey MM, Dawood M, Al-Mahtab M, Akbar SM, Rahman S, Riva A, Williams R, Taylor-Robinson SD. Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study. World J Gastroenterol 2016; 22(16): 4191-4200 [PMID: 27122669 DOI: 10.3748/wjg.v22.i16.4191] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i16/4191.htm |
| Number | Citing Articles |
| 1 |
Diren Beyoğlu, Jeffrey R. Idle. The gut microbiota – A vehicle for the prevention and treatment of hepatocellular carcinoma. Biochemical Pharmacology 2022; 204: 115225 doi: 10.1016/j.bcp.2022.115225
|
| 2 |
Yang Chen, En-Min Li, Li-Yan Xu. Guide to Metabolomics Analysis: A Bioinformatics Workflow. Metabolites 2022; 12(4): 357 doi: 10.3390/metabo12040357
|
| 3 |
Jane Macnaughtan, Francesco Figorilli, Elisabet García-López, Haw Lu, Helen Jones, Rohit Sawhney, Kaori Suzuki, Sarah Fairclough, Joanne Marsden, Alba Moratalla, I. Jane Cox, Linda Thomas, Nathan Davies, Roger Williams, Raj Mookerjee, Gavin Wright, Rajiv Jalan. A Double-Blind, Randomized Placebo-Controlled Trial of Probiotic Lactobacillus casei Shirota in Stable Cirrhotic Patients. Nutrients 2020; 12(6): 1651 doi: 10.3390/nu12061651
|
| 4 |
Ruey Leng Loo, Queenie Chan, Jeremy K. Nicholson, Elaine Holmes. Balancing the Equation: A Natural History of Trimethylamine and Trimethylamine-N-oxide. Journal of Proteome Research 2022; 21(3): 560 doi: 10.1021/acs.jproteome.1c00851
|
| 5 |
Serena De Matteis, Massimiliano Bonafè, Anna Maria Giudetti. Urinary Biomarkers. Methods in Molecular Biology 2021; 2292: 203 doi: 10.1007/978-1-0716-1354-2_18
|
| 6 |
Mei Ran Abellona U, Eric Yi-Liang Shen, Caroline Cartlidge, Alzhraa Alkhatib, Mark R. Thursz, Imam Waked, Asmaa I. Gomaa, Elaine Holmes, Rohini Sharma, Simon D. Taylor-Robinson. Optimized Systematic Review Tool: Application to Candidate Biomarkers for the Diagnosis of Hepatocellular Carcinoma. Cancer Epidemiology, Biomarkers & Prevention 2022; 31(7): 1261 doi: 10.1158/1055-9965.EPI-21-0687
|
| 7 |
Sarah S. Dinges, Annika Hohm, Lindsey A. Vandergrift, Johannes Nowak, Piet Habbel, Igor A. Kaltashov, Leo L. Cheng. Cancer metabolomic markers in urine: evidence, techniques and recommendations. Nature Reviews Urology 2019; 16(6): 339 doi: 10.1038/s41585-019-0185-3
|
| 8 |
Hui Xie, Yao-Qin Xue, Peng Liu, Peng-Jun Zhang, Sheng-Tao Tian, Zhao Yang, Zhi Guo, Hua-Ming Wang. Multi-parameter gene expression profiling of peripheral blood for early detection of hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(3): 371-378 doi: 10.3748/wjg.v24.i3.371
|
| 9 |
Xiao-Na Liu, Dan-Ni Cui, Yu-Fang Li, Yun-He Liu, Gang Liu, Lei Liu. Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis. World Journal of Gastroenterology 2019; 25(30): 4199-4212 doi: 10.3748/wjg.v25.i30.4199
|
| 10 |
Duo Zuo, Haohua An, Jianhua Li, Jiawei Xiao, Li Ren. The Application Value of Lipoprotein Particle Numbers in the Diagnosis of HBV-Related Hepatocellular Carcinoma with BCLC Stage 0-A. Journal of Personalized Medicine 2021; 11(11): 1143 doi: 10.3390/jpm11111143
|
| 11 |
Xiu Sun, Calvin Q. Pan, Huichun Xing. Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection. Hepatology International 2021; 15(5): 1053 doi: 10.1007/s12072-021-10230-6
|
| 12 |
Rachel M. Golonka, Beng San Yeoh, Matam Vijay-Kumar. Dietary Additives and Supplements Revisited: the Fewer, the Safer for Gut and Liver Health. Current Pharmacology Reports 2019; 5(4): 303 doi: 10.1007/s40495-019-00187-4
|
| 13 |
Gokula Krishnan Ramachandran, Chen Hua Yeow. Proton NMR characterization of intact primary and metastatic melanoma cells in 2D & 3D cultures. Biological Research 2017; 50(1) doi: 10.1186/s40659-017-0117-8
|
| 14 |
Nabil Mohie Abdel-Hamid, Shimaa Ali Abass. Handbook of Cancer and Immunology. 2023; : 1 doi: 10.1007/978-3-030-80962-1_148-1
|
| 15 |
Kaige Deng, Jiali Xing, Gang Xu, Bao Jin, Xueshuai Wan, Yongchang Zheng, Shunda Du, Xinting Sang. Urinary biomarkers for hepatocellular carcinoma: current knowledge for clinicians. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03092-5
|
| 16 |
Marc Cassiède, Sindhu Nair, Meghan Dueck, James Mino, Ryan McKay, Pascal Mercier, Bernadette Quémerais, Paige Lacy. Assessment of 1 H NMR-based metabolomics analysis for normalization of urinary metals against creatinine. Clinica Chimica Acta 2017; 464: 37 doi: 10.1016/j.cca.2016.10.037
|
| 17 |
Letizia Satriano, Monika Lewinska, Pedro M. Rodrigues, Jesus M. Banales, Jesper B. Andersen. Metabolic rearrangements in primary liver cancers: cause and consequences. Nature Reviews Gastroenterology & Hepatology 2019; 16(12): 748 doi: 10.1038/s41575-019-0217-8
|
| 18 |
Chao-Wei Lee, Ming-Chin Yu, Gigin Lin, Jo-Chu Chiu, Meng-Han Chiang, Chang-Mu Sung, Yi-Chung Hsieh, Tony Kuo, Cheng-Yu Lin, Hsin-I Tsai. Serum metabolites may be useful markers to assess vascular invasion and identify normal alpha-fetoprotein in hepatocellular carcinoma undergoing liver resection: a pilot study. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01885-w
|
| 19 |
Jiajia Yang, Dawei Wang, Yuancheng Li, Hongmei Wang, Qiang Hu, Ying Wang. Metabolomics in viral hepatitis: advances and review. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1189417
|
| 20 |
Xiao-Na Liu, Dan-Ni Cui, Yu-Fang Li, Yun-He Liu, Gang Liu, Lei Liu. Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis. World Journal of Gastroenterology 2019; 25(29): 4199 doi: 10.3748/wjg.v25.i29.4199
|
| 21 |
Shangfu Li, Dan Gao, Yuyang Jiang. Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma. Metabolites 2019; 9(2): 36 doi: 10.3390/metabo9020036
|
| 22 |
Lin-Lin Cao, Yi Han, Lin Pei, Zhi-Hong Yue, Bo-Yu Liu, Jing-Wen Cui, Mei Jia, Hui Wang. A Serum Metabolite Classifier for the Early Detection of Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer. Metabolites 2022; 12(7): 610 doi: 10.3390/metabo12070610
|
| 23 |
Adeleh Khodabakhshi, Vahid Monfared, Zahra Arabpour, Farhad Vahid, Motahareh Hasani. Association between Levels of Trimethylamine N-Oxide and Cancer: A Systematic Review and Meta-Analysis. Nutrition and Cancer 2023; 75(2): 402 doi: 10.1080/01635581.2022.2129080
|
| 24 |
Shi-Qin Li, Yue Shen, Jun Zhang, Cheng-Zhao Weng, Sheng-Di Wu, Wei Jiang. Immune modulation of gut microbiota and its metabolites in chronic hepatitis B. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1285556
|
| 25 |
Annabelle Pan, Thai N. Truong, Ying-Hsiu Su, Doan Y Dao. Circulating Biomarkers for the Early Diagnosis and Management of Hepatocellular Carcinoma with Potential Application in Resource-Limited Settings. Diagnostics 2023; 13(4): 676 doi: 10.3390/diagnostics13040676
|